3 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow SGX942: new trials by email Literature Review of SGX942 trials Research Report on SGX942
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dusquetide for the Treatment of Behcet's Disease Dusquetide - Behçet Disease | Phase 2 | Completed | Soligenix | 8 | 2024-11-18 | 2026-08-26 |
| DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer SGX942, Placebo - Squamous Cell Carcinoma of the Oral Cavity and Oropharynx, Oral Mucositis | Phase 3 | Completed | Soligenix | 266 | 2017-12-04 | 2022-11-08 |
| A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer SGX942, Placebo - Oral Mucositis | Phase 2 | Completed | Soligenix | 111 | 2013-12-01 | 2017-08-28 |
Stomatitis (2) · Behcet Syndrome (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Soligenix (3)
United States (2) · Belgium (1) · France (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1)